Forward Pharma A Financials
| FWPDelisted Stock | USD 2.56 0.00 0.00% |
With this module, you can analyze Forward financials for your investing period. You should be able to track the changes in Forward Pharma individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Forward |
Understanding current and past Forward Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Forward Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Forward Pharma's assets may result in an increase in income on the income statement.
The data published in Forward Pharma's official financial statements usually reflect Forward Pharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Forward Pharma A. For example, before you start analyzing numbers published by Forward accountants, it's critical to develop an understanding of what Forward Pharma's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Forward Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Forward Pharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Forward Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Forward Pharma A. Please utilize our Beneish M Score to check the likelihood of Forward Pharma's management manipulating its earnings.
Forward Pharma Stock Summary
Forward Pharma competes with Discover Financial, Pintec Technology, Commonwealth Bank, GDEV, and Blue Hat. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma AS was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Forward Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US34986J2042 |
| Business Address | Oestergade 24A, Copenhagen, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.forward-pharma.com |
| Phone | 45 33 44 42 42 |
| Currency | USD - US Dollar |
You should never invest in Forward Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Forward Stock, because this is throwing your money away. Analyzing the key information contained in Forward Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Forward Pharma Key Financial Ratios
Generally speaking, Forward Pharma's financial ratios allow both analysts and investors to convert raw data from Forward Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Forward Pharma over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Forward Pharma A reports annually and quarterly.| Return On Equity | -0.0083 | |||
| Return On Asset | -0.0342 | |||
| Target Price | 37.0 |
Forward Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Forward Pharma's current stock value. Our valuation model uses many indicators to compare Forward Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Forward Pharma competition to find correlations between indicators driving Forward Pharma's intrinsic value. More Info.Forward Pharma A is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Forward Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Forward Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Forward Pharma's earnings, one of the primary drivers of an investment's value.Forward Pharma Market Pulse
| Quote | 2.56 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 2.56 |
| Low | 2.56 |
| High | 2.56 |
| Volume | 0 |
| Exchange | NASDAQ |
About Forward Pharma Financials
What exactly are Forward Pharma Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Forward Pharma's income statement, its balance sheet, and the statement of cash flows. Potential Forward Pharma investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Forward Pharma investors may use each financial statement separately, they are all related. The changes in Forward Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Forward Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Forward Pharma Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Forward Pharma is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Forward has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Forward Pharma's financials are consistent with your investment objective using the following steps:- Review Forward Pharma's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Forward Pharma's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Forward Pharma's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Forward Pharma's stock is overvalued or undervalued.
Forward Pharma April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Forward Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Forward Pharma A. We use our internally-developed statistical techniques to arrive at the intrinsic value of Forward Pharma A based on widely used predictive technical indicators. In general, we focus on analyzing Forward Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Forward Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.18 | |||
| Information Ratio | 0.0088 | |||
| Maximum Drawdown | 44.94 | |||
| Value At Risk | (9.33) | |||
| Potential Upside | 11.65 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Forward Stock
If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |